Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Large B-Cell, Diffuse × magrolimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 9 Myelodysplastic Syndromes 3 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumor 2 Lymphoma, Non-Hodgkin 2 Lymphoma, B-Cell 2 Colorectal Neoplasms 2 Urinary Bladder Neoplasms 1 Unresectable Colorectal Cancer 1 Triple Negative Breast Neoplasms 1 Sezary Syndrome 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Myeloid Malignancies 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Hodgkin Disease 1 Carcinoma, Transitional Cell 1 Brain Neoplasms 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Rituximab 369 Cyclophosphamide 320 Vincristine 160 Prednisone 160 Doxorubicin 158 Etoposide 146 Filgrastim 99 Peripheral Blood Stem Cell Transplantation 97 Lenalidomide 91 fludarabine phosphate 82 Radiotherapy 73 Cytarabine 69 Gemcitabine 66 Mycophenolic Acid 57 Cyclosporine 55 Melphalan 54 Methotrexate 52 Ifosfamide 49 Busulfan 47 fludarabine 46 Carmustine 46 Whole-Body Irradiation 44 Carboplatin 42 Oxaliplatin 41 Tacrolimus 40 polatuzumab vedotin 36 Dexamethasone 36 Antilymphocyte Serum 36 ibrutinib 34 Magnetic Resonance Spectroscopy 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03527147 2022-08-15

PRISM

Acerta Pharma BV

Phase 1 Completed

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡